[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-KLRA":3,"homepage-market-summary":29,"stock-news-KLRA":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"KLRA","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":9,"headquarters":12,"founded":9,"is_fund":13,"issuer":9,"category":9},"Kailera Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.","Waltham, MA",false,{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":18,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},10.84,10.48,11.04,9.85,10.39,0.45,4.33,1774297.48426,18805,10.6844,28.23,898747.6877199237,5.4,118,{"status":30,"indices":31,"watchlist":74,"sectors":96,"benchmarks":151},"success",[32,40,47,54,61,67],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":59,"is_up":38,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":37,"is_up":38,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":38,"sparkline":73,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[75,82,89],{"symbol":76,"name":77,"price":78,"change":79,"pct_change":80,"is_up":38,"sparkline":81,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":13,"sparkline":88,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":38,"sparkline":95,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[97,102,107,112,117,122,127,132,137,142,146],{"name":98,"etf":99,"change":100,"price":101,"is_up":38},"Technology","XLK",0.56,200.93,{"name":103,"etf":104,"change":105,"price":106,"is_up":38},"Financials","XLF",0.73,53.88,{"name":108,"etf":109,"change":110,"price":111,"is_up":38},"Healthcare","XLV",0.72,167.37,{"name":113,"etf":114,"change":115,"price":116,"is_up":38},"Consumer Cycl","XLY",0.35,110.42,{"name":118,"etf":119,"change":120,"price":121,"is_up":38},"Consumer Staples","XLP",0.63,81.04,{"name":123,"etf":124,"change":125,"price":126,"is_up":38},"Energy","XLE",0.99,63.44,{"name":128,"etf":129,"change":130,"price":131,"is_up":38},"Industrials","XLI",0.09,170.1,{"name":133,"etf":134,"change":135,"price":136,"is_up":38},"Materials","XLB",1.31,49.5,{"name":138,"etf":139,"change":140,"price":141,"is_up":13},"Real Estate","XLRE",-0.34,40.67,{"name":143,"etf":144,"change":115,"price":145,"is_up":38},"Utilities","XLU",39.97,{"name":147,"etf":148,"change":149,"price":150,"is_up":38},"Comm Services","XLC",1.17,111.61,[152,157,162,167],{"ticker":153,"name":154,"price":155,"change":156,"is_up":38},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":158,"name":159,"price":160,"change":161,"is_up":38},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":163,"name":164,"price":165,"change":166,"is_up":38},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":168,"name":169,"price":170,"change":37,"is_up":38},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":172,"articles":173},9,[174,180,186,192,197,202,208,213,218],{"title":175,"link":176,"pubDate":177,"description":178,"source":179},"Kailera Therapeutics (NASDAQ:KLRA) Stock Falls 5.6% - Should You Sell? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxOSXNtNk1EdGt6elI0aWpzUjJwZnM2YllyakxVSVNNUnB3ZzNsOTJEOFltaFNWZGV5c0tQNGQtLVZnQVc5d2FlT3NQVGF6ekI2RTlWTzQ5RGRDVU1TbEh4cWRFSmIzQXhwd3l0STFfSm1CTml0MHNZQWlISTZPUmFaZHB5LUItbndqRTRzVGQtTnFGRjhmdkV2N05MMC1EdFcwdDJwUW5MRUF2WHBFM0hoa3JsU1lrX3l5NzhpdU1xRUQ?oc=5","Thu, 01 Oct 2026 17:48:10 GMT","Kailera Therapeutics (NASDAQ:KLRA) Stock Falls 5.6% - Should You Sell? MarketBeat","MarketBeat",{"title":181,"link":182,"pubDate":183,"description":184,"source":185},"Three trials of a weekly obesity shot have finished enrolling; results are expected in mid-2028. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxPYXVVbVRxOHZPUGJJcURTclF4YTktYk5jQlktTmREZlZzM1U2SFJRY05mNVJhOWZPbzdVSDl1YTY2dFlMRng3cjVVVEczeThGNkhfU2x2V2NvUXN3Z0FIR0FHMndka1RBU2Q4RVdLeGd0NzdzZkRKYXo1b3J6YlAxMUhKUzVvWWZ5VE5ocEl5WEtHamMxaE83QkJvZmhmWDQwRUhBZHphZDJYV1d1WGNZTExZYjFOMDJLcmR4a2Z0M1U?oc=5","Wed, 30 Sep 2026 11:00:00 GMT","Three trials of a weekly obesity shot have finished enrolling; results are expected in mid-2028. Stock Titan","Stock Titan",{"title":187,"link":188,"pubDate":189,"description":190,"source":191},"Kailera Therapeutics Announces Phase 1 Ribupatide Data Showing Flexible Injection Sites and Additional Hengrui Pharma Clinical Presentations at EASD 2026 - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAJBVV95cUxQcnhBNWJmc3Rha0lBaU9YMFBTZ1MxOWQ1WFN3MENRcEdKc2pDZlpnNjduUzhIc1VsM1NxTDNCNkdFWEwxcVNvdFBab0hYdnRYVG1lME1wMWtYaENCN25LWWtaQWlNNU02cDZxeGpiczZrOTVoWjBsd05hRFJWMXVtVzdDX0RWSXRyb3U5SG9mNk9UalBQNjBhSEIzSzV1V3kzR1hZaGpYYlJhNkVBRzJ0czVPTTBFVm15YllYRVNiazljaFBBTERrUW5uakNJY2RXZFA5NVMwb2pmTzRydHpoQV82NUpzR2o4X2RPbkswd3BmQmJVTzhNV3dqVnZ5XzY2X2lGTmZqTWNJQURCSjhLajV2LWc?oc=5","Thu, 01 Oct 2026 10:50:00 GMT","Kailera Therapeutics Announces Phase 1 Ribupatide Data Showing Flexible Injection Sites and Additional Hengrui Pharma Clinical Presentations at EASD 2026 Quiver Quantitative","Quiver Quantitative",{"title":193,"link":194,"pubDate":195,"description":196,"source":179},"868,160 Shares of Kailera Therapeutics, Inc. $KLRA Acquired by State Street Corp - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0wFBVV95cUxPOTBWb2paYWtGQ1BjMDM2Q3p6alhKUGtvaXYyM0xISjlUa0R0MTRFQzRleVVIaXFaMTgzSkR6YlZuVjBVM0UwdlprcWJxVU1nUXZjVWxwUG5uSHlnVjZta1A0MTNVdXY0U0FoTEtqNFg5WkNmenIxYXAzZmFMTVdDdDNnQV9Cb3F0YTBKZ3NnWmhuTEZyMUg4MGNIWVotUFBrMllEaGRtNVZiV3FRa3RwVDBZZk5tX1FaYmM0VDBibGhaT3NGSjJDNkd1emFXM2ZkNXdZ?oc=5","Sat, 26 Sep 2026 07:00:00 GMT","868,160 Shares of Kailera Therapeutics, Inc. $KLRA Acquired by State Street Corp MarketBeat",{"title":198,"link":199,"pubDate":200,"description":201,"source":185},"An obesity shot showed similar drug levels after injection in the arm, thigh or abdomen. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxOTzN4NkxqaUFxT1hQV1I1cmF2R1Z6V0FqTFgzSDNkanlSUjU5OHp4WEZubGl6Z1lPWTFHYm9zR1RRak9FTmVvY2k0SHB1SVBIVWJoeVo4U2xVVGgtbDBIbkl4d25pY1Z1QllhN1Qxc3dMcWYwdTdxMTE3Vy05NlVfdWZSMzM4QmdOWHBpUmVSVG05c2hKbC1VcTlYWFdjMVNJMzNWSTVwbl9yMUh5Ui1RZG0waXFlN29kQlp2WURkWQ?oc=5","Thu, 01 Oct 2026 10:45:00 GMT","An obesity shot showed similar drug levels after injection in the arm, thigh or abdomen. Stock Titan",{"title":203,"link":204,"pubDate":205,"description":206,"source":207},"Kailera Therapeutics Completes Enrollment for Trial of Ribupatide to Treat Obesity - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxPS2ZyamRaTldseVVRNElEOS0wbXhVXzJWZjEwM2pIME1VM3NObjgwQXBWM0V0UkUwTTc4c3RRbV85Q19vRk9CMVMtSEttUUhWODVpeEt5MWRIWTBCV1E0Zk8zRk1fT1hudkNucnVxYmpkNVNiQ2VQTWtMVTlkTWtrNVNqUEMyS0JjS2kwaFBhaTNQM3hTV2JqV2lSNjJjOHFBZWR0LWRnRGg1eFJuRWpaYTBFREFuR3hNcU9wY0ZnYzEtOEtlOVUxb2pIWmtYNXlK?oc=5","Wed, 30 Sep 2026 11:45:43 GMT","Kailera Therapeutics Completes Enrollment for Trial of Ribupatide to Treat Obesity marketscreener.com","marketscreener.com",{"title":209,"link":210,"pubDate":211,"description":212,"source":179},"Kailera Therapeutics (NASDAQ:KLRA) Hits New 12-Month Low - Here's Why - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxOekc1WnExNUJUQmVfaGg2RHJaWkh4TVBOb0xFTHhuQV9mVDhqYVFsbjA2VTZjR3Q1UnV2RUlpbnRNM0J1TjVCYmxtbVViaHJNWGFrNHQwNFpQTFdqZ1dIRzM2cExUT0Etck9YaHh1RXZESW5WMnMxQ1NTWTlxTUROTDhFVEpnZzhTOUx0WDkyVXE5UXdydTR5SEg4S04xWDVqdERDMUlCblBTTXZ4NjBjcGtSQkdMNUhaRjRPbndsZHRBdw?oc=5","Mon, 28 Sep 2026 15:27:25 GMT","Kailera Therapeutics (NASDAQ:KLRA) Hits New 12-Month Low - Here's Why MarketBeat",{"title":214,"link":215,"pubDate":216,"description":217,"source":179},"Kailera Therapeutics (KLRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $KLRA - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiaEFVX3lxTFAwZERLbFlRejlwTzlsTjJWYnRvMU9hdWFVNkdrY2wtRTJ1eXNLNm1TUEpDZWFBcDNPWkZOSERDRTZVTmpRRGM1OE9LckdrdExVWWpyYWJvYzBGQTAzTEZHNEVoSHFrcVV4?oc=5","Wed, 30 Sep 2026 12:05:37 GMT","Kailera Therapeutics (KLRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $KLRA MarketBeat",{"title":219,"link":220,"pubDate":221,"description":222,"source":179},"Kailera Therapeutics (NASDAQ:KLRA) Sets New 12-Month Low - Time to Sell? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxQUlhRU2REWndXNzE0TUVNeWxFbXJZdXpxSUhnWVNkYUQ1ejNha19GWTh2S0p6UFRoWWJFTmY4eDl5RUxBWDc5cUhsSWNfWVlXQ2ZvYWNCb1Axa0J2blBRNDZ2YjBseDRIX2lWalhBb1hTcXdfcmVPVFA4VGo1RjE4MkhIOG00Wmxoem5oeGoyZlplenk3N1d5Z0JybmtNMUsySjNZNUc4QkxuajkxZ0pOSjNSOHQ4YmlEMHNGX2QtNTdzSVp5b3c?oc=5","Mon, 05 Oct 2026 15:03:52 GMT","Kailera Therapeutics (NASDAQ:KLRA) Sets New 12-Month Low - Time to Sell? MarketBeat"]